Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (05): 385-390. doi: 10.3877/cma.j.issn.1674-0785.2020.05.013

Special Issue:

• Review • Previous Articles     Next Articles

Progress in clinical application of menstrual blood-derived stem cells

Xianying Cheng1,(), Jinhong Zhou1   

  1. 1. Department of Gynecology and Obstetrics, Zhejiang Hospital, Hangzhou 310030, China
  • Received:2019-11-12 Online:2020-05-15 Published:2020-05-15
  • Contact: Xianying Cheng
  • About author:
    Corresponding author: Cheng Xianying, Email:

Abstract:

Menstrual blood stem-derived cells are mesenchymal stem cells derived from menstrual blood. They have the advantages of abundant source, non-invasive acquisition, easy isolation and culture, high proliferation rate, high number of passages, low immunogenicity, and no ethical controversy. In the treatment of various diseases, menstrual blood stem-derived cells show a good therapeutic potential and have broad clinical application prospects. However, there are still many problems to be solved before they become a clinical routine treatment.

Key words: Menstrual blood-derived stem cells, Biological characteristics, Stem cell transplantation, Regenerative medicine

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd